MedElevator Войти в исследования
← Поиск публикаций

DOI 10.19746/j.cnki.issn.1009-2137.2021.06.010

Медицинская библиотека · Zhongguo shi yan xue ye xue za zhi · 2021

[Clinical Effect of Tyrosine Kinase Inhibitors in the Treatment of P230 Chronic Myeloid Leukemia].

Jiang Ya-Qin, Xu Na, Liu Xiao-Li, Wang Ji-Shi, Yuan Zhong, Huang Ji-Xian, Weng Jian-Yu, Cao Shu-Yun, Xiao Shi-Shan, Zhu Hong-Qian

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To observe the curative efficacy of tyrosine kinase inhibitors (TKIs) in the treatment of e19a2 transcript (P230) CML chronic phase (CML-CP) patients.

METHODS

The clinical data of 11 P230 CML-CP patients were collected from July 2008 to December 2019. Blood routine examination, bone marrow cytology, chromosome, and BCR-ABL qualitative and quantitative tests were performed at initial diagnosis. After TKIs treatment, BCR-ABL (P230)/ABL in peripheral blood was regularly detected to evaluate molecular response by real-time quantitative PCR.

RESULTS

There were 11 patients (7 males and 4 females) in chronic phase from 6 domestic hospitals enrolled, their median age was 46 years old (range from 19 to 56 years old). Among 4 patients treated with imatinib (400 mg, qd) firstly, 3 cases switched to nilotinib (400 mg, bid) and 1 case switched to dasatinib (100 mg, qd) due to failure to achieve best molecular response at the landmark time or mutation of ABL kinase. Then major molecular response (MMR) was obtained within 1 year. In addition, 5 patients were treated with nilotinib (300 mg, bid) and 2 patients with dasatinib (100 mg, qd) as first-line treatment, all of them got MMR within 6 months.

CONCLUSION

For intolerance or resistance to imatinib, second-generation TKIs can enable P230 CML patients to achieve deeper molecular response, and MMR in a short time.

Для цитирования: Jiang Ya-Qin, Xu Na, Liu Xiao-Li, Wang Ji-Shi, Yuan Zhong, Huang Ji-Xian, Weng Jian-Yu, Cao Shu-Yun, Xiao Shi-Shan, Zhu Hong-Qian. [Clinical Effect of Tyrosine Kinase Inhibitors in the Treatment of P230 Chronic Myeloid Leukemia].. Zhongguo shi yan xue ye xue za zhi. 2021. DOI: 10.19746/j.cnki.issn.1009-2137.2021.06.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.